• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Emergency

Direct to angiography in transferred patients with large vessel occlusion stroke associated with faster treatment and better outcomes vs repeat imaging approaches

byGursharan SohiandMichael Pratte
June 17, 2021
in Emergency, Imaging and Intervention, Neurology
Reading Time: 3 mins read
Interventional neuroradiology procedures may deliver lens radiation doses exceeding safe thresholds
Share on FacebookShare on TwitterShare on LinkedIn

1. Transferred patients with a large vessel occlusion stroke undergoing endovascular thrombectomy may have faster treatment and improved outcomes from a direct to angiography (DTA) approach versus repeated imaging.

2. Optimizing endovascular thrombectomy workflow using a DTA approach when appropriate may be associated with faster and safer reperfusion therapy.

Evidence Rating: 2b (Good)

Study Rundown: Endovascular thrombectomy (EVT) is an effective, yet time-sensitive approach to the management of stroke caused by large vessel occlusion. The optimal approach to minimizing time delays when patients are transferred from non-EVT healthcare centers to those with the appropriate facilities has not yet been described. This multi-center retrospective cohort study sought to evaluate whether repeat imaging (CT) following patient arrival at an EVT-providing stroke center may be reasonably omitted. They compared patients going directly to the angiography (DTA) suite to those receiving repeat imaging for both time to therapy and health outcomes. The primary outcome was 90-day functional status. 2533 patients were transferred to an EVT stroke center during the study period (2014-2020), of which 1140 (45.0%) went on to receive EVT. Of these patients, 28.7% went DTA, while 71.3% received repeat imaging prior to EVT. The time from arrival at the EVT center to groin puncture (receipt of EVT) was consistently shorter in the DTA group; this approach saved a median time of 26 minutes compared to repeat imaging. The rate of 90 day functional independence was likewise significantly higher in the DTA group. The study trends each 10-minute delay in EVT as attributable to a 5% decrease in 90 day functional independence. These clinical benefits of the DTA approach compared to repeat imaging lessened in magnitude as the transfer time between healthcare centers increased. Sarraj et al provide supportive evidence for bypassing repeat imaging following stroke patient transfer for provision of EVT. A primary strength of this study is its large sample size: six stroke centers across Europe and the United States were included. The analysis is comprehensive, adjusting for factors such as staff availability and time of day to validate these findings. Additionally, the primary outcome is clinically meaningful to patients beyond reducing workflow delays. A major limitation of this work is its limited external validity – there are substantial differences in stroke response protocols regionally and the feasibility of rapid transfers and imaging equipment should be considered on a center-dependent basis. Additionally, the retrospective nature of this study makes it difficult to account for clinical characteristics which may influence the decision to repeat imaging upon patient arrival.

Click to read the study in JAMA

Click to read an accompanying editorial in JAMA

RELATED REPORTS

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

Thrombectomy may improve functional independence in acute ischemic stroke with medium vessel occlusion

Relevant reading: Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

In-Depth [retrospective cohort study]: Patients were eligible for this multi-center, retrospective cohort study if they were aged 18+ and transferred from a non-EVT center to an EVT stroke center with a large vessel occlusion of the anterior circulation identified on imaging. The primary outcome of functional independence was measured using the modified Rankin Scale score. Patients were stratified on whether they received EVT within 0-6 hours of stroke onset (early window) or from 6-24 hours (late window) – DTA was found to significantly save time and improve outcomes in both cases. The median time to EVT was 34 minutes (Interquartile range [IQR] 20-62) in the DTA group and 60 minutes (IQR 37-95) in the repeat imaging group (p < 0.001). The adjusted odds ratio for 90-day functional outcomes in the DTA vs. repeat imaging group was 1.85 (95% confidence interval 1.33-2.57). The effect size was larger in the adjusted odds ratio compared to the naive odds ratio after accounting for certain patient factors (i.e., stroke severity score, serum glucose). There was a trend towards lower 3-month mortality in the DTA group as well, but this only reached statistical significance in patients treated with EVT in the early window (13.1% DTA group mortality, 21.7% repeat imaging mortality, p=0.01).

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: angiographyischemic strokestroke
Previous Post

Chemotherapy during the first trimester of pregnancy associated with increased risk for congenital malformations in fetus

Next Post

Annual screening for ovarian cancer does not significantly reduce mortality

RelatedReports

A detailed illustration of a kidney and glomeruli, with a pill depicted, representing treatment for kidney-related conditions. It suggests a focus on chronic kidney disease.
Nephrology

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

September 9, 2026
Ischemic stroke collage: an engraved brain with one artery traced in teal and a small clot lifted away on a ribbon
Neurology

Thrombectomy may improve functional independence in acute ischemic stroke with medium vessel occlusion

May 26, 2026
Ischemic stroke collage: an engraved brain with one artery traced in blue beside a glass hourglass on graph paper
Weekly Rewinds

2 Minute Medicine Rewind April 20, 2026

April 20, 2026
Ischemic stroke collage: an engraved brain with one artery traced in blue beside a glass hourglass on graph paper
Chronic Disease

Virtual reality rehabilitation is safe and feasible for upper extremity recovery after subacute ischemic stroke

February 25, 2026
Next Post
Quick Take: Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma

Annual screening for ovarian cancer does not significantly reduce mortality

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Multisystem inflammatory syndrome in children remains a rare but serious complication associated with SARS-CoV-2 infection

Postpartum mental illness increased in frequency during the COVID-19 pandemic

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Non-inpatient care settings may offer alternatives to inpatient beds for select patients
  • Pirtobrutinib improves progression-free survival versus bendamustine plus rituximab in previously untreated CLL/SLL
  • Angiography-derived vessel fractional flow reserve (vFFR) was noninferior to pressure wire–based fractional flow reserve (FFR) for guiding revascularization in intermediate coronary stenoses
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.